Merida Biosciences Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • M&A

Merida Biosciences General Information

Description

Developer of targeted immunotherapies designed for the treatment of autoimmune and allergic diseases. The company's platform focuses on the selective elimination of disease-causing antibody-producing cells while sparing healthy immune function, enabling healthcare providers to address underlying disease mechanisms more effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 500 Technology Square
  • Suite 1401
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 500 Technology Square
  • Suite 1401
  • Cambridge, MA 02139
  • United States

Merida Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merida Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 31-Aug-2026 Completed Clinical Trials - General
3. Early Stage VC (Series A) 08-Apr-2025 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Apr-2023 $33M Completed Pre-Clinical Trials
1. Seed Round 01-Jan-2022 $33M $33M Completed Pre-Clinical Trials
To view Merida Biosciences’s complete valuation and funding history, request access »

Merida Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Merida Biosciences’s complete cap table history, request access »

Merida Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merida Biosciences FAQs

  • When was Merida Biosciences founded?

    Merida Biosciences was founded in 2022.

  • Where is Merida Biosciences headquartered?

    Merida Biosciences is headquartered in Cambridge, MA.

  • What is the size of Merida Biosciences?

    Merida Biosciences has 45 total employees.

  • What industry is Merida Biosciences in?

    Merida Biosciences’s primary industry is Drug Discovery.

  • Is Merida Biosciences a private or public company?

    Merida Biosciences is a Private company.

  • What is Merida Biosciences’s current revenue?

    The current revenue for Merida Biosciences is .

  • How much funding has Merida Biosciences raised over time?

    Merida Biosciences has raised $154M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process